Limit of detection (LOD), limit of quantification, and the dynamic range of detection of hepatitis B surface antigen antibody (anti-HBs) using a surface plasmon resonance (SPR) chip-based approach with Pichia pastoris-derived recombinant hepatitis B surface antigen (HBsAg) as recognition element were established through the scouting for optimal conditions for the improvement of immobilization efficiency and in the use of optimal regeneration buffer. Recombinant HBsAg was immobilized onto the sensor surface of a CM5 chip at a concentration of 150 mg/L in sodium acetate buffer at pH 4 with added 0.6% Triton X-100. A regeneration solution of 20 mM HCl was optimally found to effectively unbind analytes from the ligand, thus allowing for multiple screening cycles. A dynamic range of detection of ß0.00098-0.25 mg/L was obtained, and a sevenfold higher LOD, as well as a twofold increase in coefficient of variance of the replicated results, was shown as compared with enzyme-linked immunosorbent assay (ELISA). Evaluation of the assay for specificity showed no cross-reactivity with other antibodies tested. The ability of SPR chip-based assay and ELISA to detect anti-HBs in human serum was comparable, indicating that the SPR chip-based assay with its multiple screening capacity has greater advantage over ELISA.
Introduction
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV) [1, 2] . Worldwide, it is estimated that more than 240 million people have chronic hepatitis B infections [3, 4] , and it is responsible for approximately 600,000 deaths per year from acute infection and hepatitis-related liver cancer and cirrhosis [5] . Because of the significant burden it places on communities across all global regions, the World Health Assembly of the World Health Organization adopted the first "Global Health Sector Strategy on Viral Hepatitis, 2016-2021" that highlights the need to monitor viral hepatitis prevention, diagnosis, and treatment progress [6] . Notably, hepatitis B surface antigen antibody (anti-HBs) serves as an important serological marker in monitoring the success of hepatitis B vaccination [7] and as an indicator for disease resolution as well as in the determination of the recovery of hepatitis B infected individuals [8] .
Current gold standard immunoassays, although they play prominent roles in the detection and diagnosis of anti-HBs [9] , have shortcomings associated with time, indirect format, labor intensity, cost and the need for multiple washing steps, and increased risk of contamination [10] . In the search for greater efficiency in hepatitis detection, the surface plasmon resonance (SPR) based assays have shown to be of great potential [11] . Among the unique features of the SPR sensors is the ability to map epitopes for antigen-antibody interactions. For anti-HBs detection, the SPR sensor technique involves the use of whole human HBV as a recognition element, and because of the limited detection range, this technique is inadequate for clinical use. As a consequence, signal amplification labels were used to enhance the detection limit of the SPR sensor based assay to improve the detection method [12] . Although encouraging, the use of signal amplification labels is often limited by poor solubility and stability, and more importantly, lack of control over the response of complex biological samples [10] . In another application, anti-HBs utilizing molecular imprinted technology (MIT) incorporating poly(hydroxyethyl methacrylate-N-methacryloyll-tyrosine methyl ester) (PHEMAT) film was applied as the recognition element in the detection of anti-HBs [13] . This technique is reliable but still fraught with relative lack of sensitivity. One of the major concerns with MIT is the leakage of the imprint molecules, which could lead to uncertainty in the determination of concentration [14] . The MIT is also limited by the ineffectiveness in the removal of analyte molecules from the imprinted materials once the polymer is formed, contributing to errors and an increase in the limit of quantification (LOQ) [15] .
Alternatively, the performance of the SPR assay can be enhanced with the improvement of immobilization efficiency of the antigen as recognition element on sensor chip surfaces [16] . This can be done by taking into full consideration the factors influencing immobilization efficiency such as the binding conditions between the solid surface and recognition elements its level and conservation of bioactivity after immobilization, as well as optimization of regeneration condition that has shown to improve the performance of SPR assays [17, 18] . In addition, recombinant hepatitis B surface antigen (HBsAg) derived from Pichia pastoris could be used as the recognition element in the detection of anti-HBs with the application of SPR principles. The HBsAg, particularly the S protein with high epitope density, has a high reactivity with anti-HBs [19] . The P. pastoris has an additional advantage in that none of its proteins cross-react immunologically with normal human serum proteins [20, 21] , thus eliminating the possibility of false-positive results when the recombinant protein derived from this host is used in the immunoassay. These factors are crucial in immunoassay development, particularly because they affect the accuracy, sensitivity, and specificity [19, 22, 23] .
The present work employed P. pastoris-derived HBsAg in the establishment and validation of an SPR chip-based anti-HBs detection assay. In this study, we described the effects of binding conditions on recombinant HBsAg surface immobilization involving the influences of pH, Triton X-100, and HBsAg concentration. A suitable surface regeneration buffer was identified and specificity of the assay was highlighted by the HBsAg-antibody interaction. Calibration curves were generated with data fitting and determination of limit of detection (LOD) and LOQ as well as the coefficient of variance (CV) of the assay were carried out. The applicability of SPR chip-based assay for the detection and quantification of antiHBs from human sera is demonstrated in comparison to a commercial enzyme-linked immunosorbent assay (ELISA) kit. Through improved immobilization efficiency and in the use of optimal regeneration buffer, the assay presented points to a higher accuracy in reading replicated samples and sensitivity with a wider dynamic range of detection for the measuring of anti-HBs in real-time samples in a label-free environment.
Experimental

Materials and reagents
The reagents used in the study were standard monoclonal anti-HBs (Meridian Life Science, Memphis, TN, USA; Merck Calbiochem, Germany), mouse extracellular matrix metalloproteinase inducer antibody (anti-EMMPRIN) (R & D Systems, Minneapolis, MN, USA), mouse monoclonal interferon antibody (anti-IFN) antibody (Merck, Kenilworth, NJ, USA), human monoclonal epidermal growth factor antibody (anti-EGF) (Merck Calbiochem), anti-HBs detection ELISA kit (SURASE B-96 [3,3 ,5,5 -tetramethylbenzidine, TMB]) (General Biologicals Corp., Hsinchu, Taiwan), sensor chip CM5 and amine coupling kit containing 0.2 M 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and 0.05 M N-hydroxysuccinimide (NHS) and 1 M ethanolamine hydrochloride (pH 8.5) (GE Healthcare, Buckinghamshire, UK), and 66 human remnant serum samples (National Blood Center, Kuala Lumpu, Malaysia). The standard monoclonal anti-HBs was used as positive control, whereas HBS-EP buffer was used as negative control. The HBS-EP buffer (0.01 M HEPES, 0.15 M NaCl, 0.003 M EDTA, 0.005% Tween-20, pH 7.4), sodium acetate buffers (0.01 M sodium acetate, with pH 4.0-5.5 adjusted by adding 1 M HCl), and regeneration buffers were prepared in house, filtered using 0.22 μm filter and degassed prior to use.
Recombinant HBsAg was expressed from P. pastoris according to the methods described previously [1, 24] . Briefly, production of intracellular HBsAg recombinant protein from P. pastoris (GS115 strain, methanol utilization plus [Mut + ]) was cultivated using fed-batch fermentation. After 48 H postinduction, P. pastoris culture was harvested by centrifugation at 2,860g and 4
• C for 10 Min. The cell pellet was resuspended and washed twice by centrifugation at 2,860g in ice-chilled 20 mM Tris-HCl buffer (pH 7). The cell pellet was resuspended in the same buffer and disrupted using a high-pressure homogenizer (Homogenizer Emulsiflex-C50; Avestin, Ottawa, ON, Canada) for 20 passes, at 7.70 g/L dry cell weight of biomass concentration, and pulse pressure at 1,029 bar. Recovery and purification of the P. pastoris-derived HBsAg were then performed using a two-step purification method involving ion-exchange chromatography (IEC) and size-exclusion chromatography.
Biosensor system
All analyses were performed using a fully automated Biacore R 3000 (GE Healthcare, Little Chalfont, United Kingdom) microfluidic system with precision liquid handling. Detection of anti-HBs was based on changes in SPR signals as a result of interaction between antibody and recombinant HBsAg immobilized onto semifluidic matrix on the gold surface sensor chip. Samples containing anti-HBs were injected over the sensor surface in real-time assay format. The change in response is proportional to the change in mass at the surface and expressed as response unit (RU). HBS-EP buffer (10 mM HEPES with 0.15 M NaCl, 3.4 mM EDTA and 0.05% surfactant P20 at pH 7.4) was used as the continuous running buffer at 5 μL/Min flow rate. All experiments were carried out at 25
• C with sensor chip CM5 and the results were further analyzed with BIA evaluation software (Version 4.1).
Screening for optimum HBsAg immobilization conditions
The effect of buffer pH, Triton X-10, and HBsAg concentration on the production of optimized immobilization conditions was determined. This was carried out with buffer at a pH range of 3.0-5.5 at a flow rate of 20 μL/Min and Triton X-100 of 0-1%, at a total exposure time of 2 Min. Determination of optimum HBsAg concentration was performed at pH 4, using antigen at the concentration of 20-200 mg/mL and 0.6% Triton X-100 with the same exposure time and flow rate as per pH determination. Electrostatically adsorbed proteins were removed using the 10 mM glycine-HCl at pH 2 as the regeneration solution.
Immobilization of HBsAg
Immobilization of HBsAg to sensor chip CM5 was performed using a standard coupling protocol as previously described via exposed primary amines [17] . In this procedure, a continuous flow of 5 μL/Min HBS-EP buffer was maintained over the sensor surface. Prior to immobilization, the sensor surface was exposed to 0.1 M HCl, 0.05 M NaOH, and 0.5% SDS, in order, for 2 Min at a flow rate of 20 μL/Min. To immobilize the antigen, carboxylated matrix on the sensor surface was activated by an injecting a solution containing 0.2 M EDC and 0.05 M NHS at equal volumes at a flow rate of 5 μL/Min for 7 Min. The HBsAg in 10 mM sodium acetate buffer at pH 4.0 was then injected at a rate of 1.0 mL/Min for 1 Min exposure, with repetition until the maximum reaction unit (RU) was obtained. The surface was then inactivated, and the remaining unreacted NHS-ester groups were blocked with 1 M ethanolamine-HCl at a flow rate of 5 μL/Min for 7 Min. The immobilization ligand was replaced with HBS-EP buffer before inactivation of carboxylated matrix and served as the negative control.
Regeneration studies
After immobilization, scouting for an optimized regeneration solution was evaluated with HBS-EP buffer as negative control, 100 mM HCl, 10 mM phosphoric acid, 0.15% SDS, 0.5 M KCl, and 100 mM NaOH. Monoclonal anti-HBs (10 mg/L) as the analyte in HBs-EP running buffer was injected at 20 μL/Min for 1 Min through the HBsAg surface, and then the respective regeneration solution passed through for 30 Sec at a flow rate of 20 μL/Min. The procedure was repeated thrice to ensure consistency and reproducibility.
Validation studies on the established chip-based assay
The performance of the anti-HBs detection assay was determined using monoclonal anti-HBs at a concentration range of 0.1-10.0 mg/L. The acceptable calibration and linearity range, maximum binding capacity of anti-HBs, LOD, and LOQ for the assay was determined. To ascertain that there was no cross-reactivity, samples comprising anti-EMMPRIN, anti-IFN, and anti-EGF were used. Monoclonal anti-HBs that served as control was evaluated at concentrations of 0.01, 0.1, and 1 mg/L to determine the specificity of the assay. Validation of the anti-HBs chip was done using human sera. The serum samples, in triplicate, were diluted in HBS-EP buffer at ratios of 1:20 to 1:100, which are concentrations within the standard linear curve range established for the assay. The CV of the assay for the samples was calculated. The concentrations of anti-HBs in the samples were also evaluated using the commercial ELISA kit.
ELISA
Samples used in the experiment were tested for anti-HBs using ELISA (EIAgen anti-HBsAg kit; Adaltis, Italy) kit according to the protocol provided by the manufacturer. Briefly, 50 μL specimen diluent was placed in the well of 96-well plate followed by the addition of 100 μL of sample. Thereafter, the plate was incubated for 60 Min at 37
• C. After incubation, the plate was then washed thrice with 200 μL 20× washing buffer. Subsequently, 100 μL of enzyme conjugate solution containing horseradish peroxidase-labeled HBsAg was added to the wells and the plate was incubated for another 60 Min at 37
• C. The plates were again similarly washed and the substrate solution of TMB/ hydrogen peroxide mixture was added and the plate was incubated for another 20 Min at 25
• C. The enzymatic reaction was stopped by adding 100 μL sulfuric acid and plate reads in an ELISA reader (Tecan, Sunrise, Australia) at a wavelength of 450 nm with a reference wavelength of 630 nm.
Quantification of anti-HBs
Human serum samples containing anti-HBs and standard monoclonal anti-HBs were diluted with HBS-EP running buffer and passed over the reference and immobilized HBsAg at a flow rate of 5 μL/Min flow rate for 2 Min. The RU value was read at 30 Sec before and 100 Sec after the end injection. After each measurement, the sensor surface was regeneration buffer (20 mM HCl) was injected with a flow rate of 5 μL/Min for 10 Min and washed with HBS-EP running buffer prior to subsequent injections. Each sample was analyzed in triplicate. Anti-HBs was prepared at a concentration ranging from 0 to 0.25 mg/mL for the generation of the standard curve. Values higher than 0.00781 mg/L are considered positive for the presence of anti-HBs [25] .
Calculation of LOD and LOQ
The LOD of the assay describes its ability to detect analyte, which is defined by the International Union of Pure and Applied Chemistry (IUPAC) as the lowest distinguishable analyte concentration from the absence (C LOD ) of analyte, derived from the smallest measured value (Y LOD ) that can be detected within a predetermined confidence limit [26] . Y LOD value can be calculated from the following equation:
where Y blank is the mean of the blank measures (sample without analyte), σ blank is the standard deviation of the blank measures, and m is a numerical factor determined according to a level of reasonable certainty (m = 3) [27] . The C LOD can be calculated from the following equations:
where S conc is the sensitivity of the assay (slope of the calibration curve) [28] . Since LOD defines the concentration that indicates the presence of analyte rather than a quantification of analyte concentration, the LOQ is used instead. The LOQ is defined as the lowest concentration of analyte that could still be quantified within predetermined acceptable precision (m = 10) [28] . The C LOQ can be calculated from the following equation:
To describe the interaction between anti-HBs and HBsAg, a fitting equilibrium model using Langmuir isotherm equation [29] was used to determine the maximum binding capacity (R max ) of anti-HBs to HBsAg as follows:
where R and R max are the amount and maximum amount, respectively, of adsorbed anti-HBs, C is the anti-HBs concentration, and K D represents the dissociation constant of anti-HBs. The molar ratio of the antigen-antibody interaction can be demonstrated by calculating the maximum binding ratio of the
FIG. 1
Optimum molecular masses of the analyte and ligand [30] . The formula for maximum binding ratio (r) is as follows:
where MW anti-HBs and MW HBsAg are molecular weights of antiHBs (150 kDa) and HBsAg (25 kDa), respectively, and n is the mass anti-HBs saturated per unit mass HBsAg.
To further determine the accuracy of the SPR chip-based assay in the detection and quantification of anti-HBs from human sera samples, the anti-HBs concentrations determined by SPR chip-based assay was validated with the results obtained by ELISA. Percentage deviation between the results was calculated using the following equation:
Chip − based assay anti−HBs -ELISA anti−HBs ELISA anti−HBs × 100 (6) where chip-based assay anti-HBs and ELISA anti-HBs are the concentrations of anti-HBs determined by SPR chip-based assay and ELISA, respectively, from human sera samples [31] .
Results
Optimization of HBsAg binding conditions on sensor surface scouting
Carboxylated dextran-HBsAg interaction attraction under the influence of pH is shown in Fig. 1 . pH 4 generated the highest HBsAg adsorption to dextran surface with the highest relative response of ß2,800 RU, followed by pH 4.5 with a relative response of ß1,500 RU. HBsAg adsorption was weaker at buffer pH 5.0. There was no HBsAg-dextran surface interaction at buffer pH of 5.5. Interactions on HBsAg-dextran surface are also influenced by the concentration of Triton X-100. The greatest interaction was with 0.6% Triton-X-100 with a relative response ß3,500 RU (Fig. 2) . The HBsAgdextran surface interaction was again investigated using various HBsAg concentrations at buffer pH 4 and 0.6% Triton X-100. Generally, the attraction of HBsAg to the dextran surface increased with HBsAg concentration with the minimum most effective concentration at 50 mg/L of the protein (Fig. 3) . From the results, the optimum HBsAg concentration is 150 mg/L, where adsorption of HBsAg on the dextran was the highest with a relative response of ß7,950 RU. Thus, the study showed that optimized condition for generation of the greatest HBsAgdextran surface interaction is 150 mg/L HBsAg in 0.6% Triton X-100 at pH 4. This condition was used for the immobilization of HBsAg on the sensor chip CM5.
FIG. 4
HBsAg 
HBsAg immobilization on surface of sensor chip CM5
The result from immobilization of HBsAg on the sensor chip is shown in Fig. 4 . The immobilization of HBsAg generated a response value of 7,695 RU, corresponding to approximately 7.7 ng/mm 2 surface concentration, based on the premise that change in SPR signal of 1,000 RU is equivalent to an increase in the mass of sensing matrix of approximately 1 ng/mm 2 [32] .
Chip surface regeneration
The stability of the HBsAg surface on the sensor chip was investigated by repeated injections of standard monoclonal anti-HBs and surface regenerations. It was shown that 0.15% SDS and 100 mM H 2 PO 4 were too mild for efficient surface regeneration because the complete dissociation of anti-HBs bound to the HBsAg surface was not observed as indicated by the increase in baseline level and reduction in response level (Fig. 5) ; 0.15% SDS was weaker than 100 nM H 2 PO 4 solution with a higher difference of baseline level ( 500 RU) and near to 0 RU response level at the end of the cycles. On the other hand, 100 mM of either HCl or NaOH were too harsh, causing significant and irreversible loss of HBsAg ligand bioactivity. Among the regeneration solutions used in the study, 20 mM HCl and 10 mM glycine-HCl at pH 2 provided satisfactory results. Thus, 20 mM HCl, since it gave the most stable response, was chosen as the regeneration solution for subsequent analyses.
Assay calibration and determination of LOD and quantification LOQ
A standard curve was constructed using standard monoclonal anti-HBs at a concentration ranging from 0 to 10 mg/L where a polynomial relationship was observed with respect to its relative response (Fig. 6 ). The calculated Y LOD value was determined to be as ß0.5 RU and as such, the concentration of LOD was estimated to be 0.00098 mg/L, while the concentration of LOQ 
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FIG. 5
Regeneration and surface stability of SPR sensor chip CM5. (A) 20 mM HCl, (B) 10 mM glycine-HCl at pH 2.0, (C) 100 mM H 2 PO 4 , (D) 100 mM HCl, (E) 100 mM NaOH, and (F) 0.15% SDS buffers were evaluated for surface regeneration under repeated five cycles. Monoclonal anti-HBs (10 mg/L) in
FIG. 6
Anti-HBs calibration curve. The concentration range used was 0-10 mg/L of antibody.
was estimated to be 0.00781 mg/L based on dilution series of the standard monoclonal anti-HBs and calculated using Eq. (1)- (3), respectively. The data were further fitted to the
FIG. 7
Maximum The dynamic range of the calibration curve, which was defined as the concentration range with a correlation of coefficient (R 2 ) > 0.95, was determined by linear fitting in the range of 0.00098-0.25 mg/L anti-HBs concentration (R 2 > 0.99) (Fig. 8) . The CV generated by the repeated injections of monoclonal anti-HBs onto the recombinant HBsAg surface was found to be from 0.03 to 7.64%, illustrating good reproducibility of the assay (Table S1 in the Supporting Information).
Specificity of the assay
To determine the specificity of interaction of serum with the recombinant HBsAg on the sensor surface, several concentrations of anti-EMMPRIN, anti-IFN, and anti-EGF were reacted with recombinant HBsAg on the sensor surface with the deactivated sensor surface served as reference (Fig. 9) . Monoclonal anti-HBs interacted well with the HBsAg on the sensor surface while other antibodies at all concentrations failed to produce measurable relative responses with values less than the LOD. The results showed that the SPR chip-based assay is highly specific for anti-HBs detection.
Correlation between the SPR assay and ELISA in the detection of anti-HBs in serum
A comparison of the performance of the chip-based assay versus ELISA in the detection of anti-HBs was made. In this experiment, the evaluations were made on diluted sera. Generally, using the SPR chip-based assay, a dilution ratio of 1:100 was sufficient for the detection of anti-HBs of concentration
FIG. 9
HBsAg-anti-HBs binding specificity. 
FIG. 10
Comparison of deviation among the results of the SPR chip-based assay and ELISA in the quantification of anti-HBs in human sera (n = 66). Percentage deviation was calculated and the majority of the values deviated by <10% with a mean percentage deviation of -0.27, indicating that the SPR chip-based assay is comparable to ELISA in the quantification of anti-HBs.
within the standard curve range. Samples negative for antiHBs were diluted to 1:20 and served as controls (Table S2 in the Supporting Information). The accuracy of the results, as a measure of closeness between the values obtained from both assays, was reported as the percentage of deviation (Fig. 10) .
The response values obtained using chip-based assay corresponded well with that of ELISA within deviations of <15%. In the quantification of samples, considerably (P < 0.05) lower CV (4.88%) than the ELISA (28.13%) was also observed in the SPR chip-based assay. In the ELISA, the lower LOD of antiHBs was 0.0078 mg/L, while the upper LOD was 0.0312 mg/L. The results suggest that the SPR chip-based assay is similar in sensitivity to the commercial ELISA kit in the detection of antiHBs in human serum samples. However, the chip-based assay has a wider dynamic range of detection and quantification of the antibody.
Discussion
In immunoassays, immobilization of the maximum possible amount of antigen is often required to ensure the greatest antibody binding and to increase the sensitivity and stability of the antigen-antibody complex on the surface of the chip [33] . Using standard amine coupling procedure, the optimal immobilization of the HBsAg was with a buffer of pH 4. The greatest level of immobilization was shown to occur with the use of 0.6% Triton X-100 at an antigen concentration of 150 mg HBsAg protein per liter. Under these conditions, as much as 96.8% of the injected protein was adsorbed on the surface of the chip. This binding efficiency of the HBsAg in this assay was better than previously reported (60-80%) for dust mite allergen [34] . The higher level of immobilization in the present study is attributed to Triton X-100 that had improved chemical coupling by exposing nonparticle-associated lipids and amine groups of recombinant HBsAg and allowing for greater binding to the surface of the chip [11] . The level immobilization of the recombinant HBsAg to the sensor surface after activation was shown to increase when the immobilization process was repeated several times [29] . It seems that doubling the exposure time of the sensor surface increased immobilization of anti-HBs by as much as ninefold greater than the initial level. Protein adsorption to the ligand is via primary amine groups and is determined by interfacial forces between the activated surface dextran-based carboxymethyl groups and proteins. The forces include electrostatic interactions, dispersion and hydration forces, and steric-entropic effects that are all still dependent on the chemical composition and structure of the surface dextran [35] . The coupling of the proteins to the ligands is random and the amount immobilized is determined by the rate of reaction [36] . Currently, it is not known how the time of exposure of the ligand correlates with the degree of immobilization.
The chip-based assay is performed under a continuous flow environment. Naturally, the liquid medium will affect quality and quantity of protein immobilization on the sensor surface. The effect of the liquid medium on the effectiveness and reproducibility of protein immobilization was investigated in this study. It was shown that 10 mM glycine-HCl at pH 2 and 20 mM HCl were found to be best buffers for the removal of bound anti-HBs while maintaining surface activity. The effective regeneration buffer for sensor chip surface HBsAg antigenantibody interactions was 20-50 mM HCl. Thus, for the purpose of this study, 20 mM HCl was chosen as regeneration buffer because it provided consistency in baseline value and surface activity of the chip after several cycles of regeneration. This is important in a biosensor assay to avoid any response drift during the process of detection that could affect the accuracy of the results [37] . Response drift was not observed in this study. This was evident by the low CV among the calibration curves. Previous studies reported a downward drift of sample response especially after prolonged use of the sensor chip in the analyses. For instance, in the detection of Phytophthora infestans, a decrease of 6% in surface activity occurred after 110 regeneration cycles that finally reached 20% by the end of the study [38] . In our study, the calibration was performed for every 20 samples to ensure that the surface activity of the assay does not decrease by more than the recommended 20% of its initial activity for repetitive regeneration assays [37, 39] .
The LOD and LOQ of the SPR chip-based assay in this study were 0.00098 and 0.00781 mg/L, respectively, with a dynamic linear range of up to 0.25 mg/L. In the case of ELISA, the linear range for ELISA was 0.00781-0.0312 mg/L. Thus, the SPR chip-based assay had a wider range of linearity than ELISA in the detection of anti-HBs. In earlier studies using whole human HBV as the recognition element, a LOD of 0.096 mg/L was achieved with the use of peroxidase-anti-peroxidase (PAP) complex label proteins [12] . In the use of gold-binding polypeptide fused to PreS2-HBsAg as the recognition element, the dynamic detection range for the detection of anti-HBs with SPR was 1-5 mg/L [40] . Another study reported that SPR chip with anti-HBs MIT imprinted PHEMAT film was able to detect the anti-HBs from human sera with 99.7% precision with the detection range of 0-0.00781 mg/L [13] . The relatively wider dynamic range from this study would be valuable for the detection and quantification of anti-HBs in human samples [12] . In our study, a low LOD was able to be achieved without the need for signal amplification labels using recombinant HBsAg S protein as the recognition element. A downward drift of sample responses after prolonged use of chip-based assay was also not observed, indicating stability in the system. This could be due to the presence of a relatively high amount of cysteine residues in HBsAg S protein [41] , which is essential for the formation of covalent bonds with the gold surface of the SPR chip [40] . Taken altogether, it was observed that the chip-based assay established in this study was able to overcome the shortcomings that could occur from the use the other recognition elements in the previous studies [12, 13, 40] .
The Langmuir model, which is a homogeneous binding site model, is used commonly to fit binding isotherms for direct interactions in SPR assays [13, 29, 42] . In this study, there was a high correlation coefficient between Langmuir isotherm model and the experimental data, indicating that the equation is acceptable for use to describe the interaction between antiHBs and immobilized HBsAg. This high correlation coefficient also indicated that adsorption of proteins to the surface of the sensor was monolayer in nature with homogeneous binding. The Langmuir isotherm model also demonstrated that in the SPR chip-based assay, at a given HBsAg concentration, the antiHBs binding activity at saturation is approximately 16.7%. What this indicates is that there is a possibility of steric hindrance that results in failure of some immobilized antigens to bind to the anti-HBs [30] . In the case of amine coupling, immobilization of ligand onto the sensor surface is nonspecific; thus binding interference may occur as the result of conformational changes in the binding sites or formation of ligand subpopulations of variable orientations and affinities that had sterically restricted access to the binding partners [43] .
The analysis performed was based on the assumption that the data are in accordance with the simple one-to-one unimolecular rate of reaction that integrates the pseudo-firstorder kinetics. The data describe the best accessible binding sites for the HBsAg and anti-HBs and assume to represent their affinities in solution. However, if the molecular sizes of HBsAg and anti-HBs were to be taken into consideration, where HBsAg is significantly smaller than the anti-HBs molecule, the inaccessibility of anti-HBs to the binding sites on HBsAg would then be the result of mass transport limitation by which the access of subsequent free antibody molecules to the binding sites on the HBsAg molecule is restricted by the already bound antibody molecules, particularly when the density of immobilized ligand is high [44, 45] .
The performance of the chip-based assay was validated with human remnant serum samples. As shown in the results, just like in the ELISA, human serum was specific for immobilized HBsAg, indicating that the SPR chip-based assay is specific for anti-HBs detection. The deviation of the assay was less than 20%, which is, according to International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, acceptable as an indicator of the accuracy of the assay [46] . The deviation among the results of the SPR chip-based assay and ELISA can be due to the differences in antibody binding kinetics of the two assays. For example, in ELISA, where a long incubation period is routinely employed, there is high antibody-antigen association during binding. In the SPR chip-based assay, the antibody-antigen association is determined real-time, the detection sensitivity is expectedly lesser than in the ELISA [47, 48] . Nevertheless, the results obtained in this study appeared to be in good agreement within the limits of experimental uncertainty, similar to other studies that compared the SPR biosensor assay with ELISA [36, 49] .
In SPR chip-based assays, the inclusion of a reference surface during the analysis of samples is highly useful in the correction for nonspecific background absorption and to compensate for refractive index differences. This is particularly important when differentiation between responses of low concentration and negative samples becomes a critical factor. Thus, the level of confidence and accuracy of the SPR chipbased assay detection is greatly dependent on incorporation of samples on the surface of sensor and rate of interaction between the HBsAg and the anti-HBs [50] [51] [52] .
In summary, immobilized recombinant HBsAg derived from P. pastoris as the recognition element was shown to be a practical and simple one-step analytical method for the detection of anti-HBs. The regeneration of the sensor using HCl facilitated strong affinity of HBsAg to sensor dextran surface. Evaluation of the SPR chip-based assay using the Langmuir's adsorption isotherm for anti-HBs interaction showed a specific interaction between HBsAg and the antibody, indicating that there are homogenous binding and monolayer adsorption of the proteins on the sensor surface. On the basis of maximum binding ratio, an estimated of six HBsAg molecules were needed to bind one anti-HBs molecule at saturation. In addition, the upper limit of the assay was found to be eightfold higher than that of the ELISA with a sevenfold lower LOD, yielding a wider linear dynamic range of detection and quantification of anti-HBs. Comparison between assays showed that the SPR chip-based assay was more accurate at reading replicated samples. In conclusion, the SPR chip-based assay for anti-HBs is not only accurate and sensitive but also has great potential for the estimation of anti-HBs in a non-labeling real-time environment.
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